Home › Ovarian Epithelial Carcinoma › Utah
Ovarian Epithelial Carcinoma clinical trials in Utah
6 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in Utah.
Cities in Utah
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Utah Cancer Specialists Network, Salt Lake City
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 28, 2026 · NCT06819007Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
- Research Site, Salt Lake City
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 16, 2026 · NCT07816666ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Utah Cancer Specialists, Salt Lake City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05059444Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Recruiting
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT05297734A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- START Center for Cancer Care - Mountain Region, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
- LDS Hospital, Salt Lake City
RecruitingPhase 1
Ages 18 and older · Women · Updated Feb 3, 2026 · NCT06469281From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.